Reporte zur Charge EW01706

Symptomtext

Chest pain with deep breath; Nausea; Head ache; Arm discomfort; Fatigue; Cough; This is a spontaneous report received from contactable Nurse (Other HCP). A 34-year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 17Aug2021 15:00 (Lot number: EW01706) at the age of 33 years as dose 1, 0.3 ml single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: CHEST PAIN (non-serious) with onset 17Aug2021 22:00, outcome "not recovered", described as "Chest pain with deep breath"; NAUSEA (non-serious) with onset 17Aug2021 22:00, outcome "not recovered", described as "Nausea"; HEADACHE (non-serious) with onset 17Aug2021 22:00, outcome "not recovered", described as "Head ache"; LIMB DISCOMFORT (non-serious) with onset 17Aug2021 22:00, outcome "not recovered", described as "Arm discomfort"; FATIGUE (non-serious) with onset 17Aug2021 22:00, outcome "not recovered", described as "Fatigue"; COUGH (non-serious) with onset 17Aug2021 22:00, outcome "not recovered", described as "Cough". The events "chest pain with deep breath", "nausea", "headache", "arm discomfort", "fatigue" and "cough" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of chest pain, nausea, headache, limb discomfort, fatigue, cough. Additional Information: Facility where the most recent COVID-19 vaccine administered was Doctor's office/urgent care. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.The patient did not receive any other medication within 2 weeks of vaccination. Patient received 0.3ml of vaccine non reconstituted. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19 (nasal swab) with negative result. The reported known Allergies were NKA. Follow-up attempts are completed. No further information is expected.